P‐CB‐21 | RBC Alloimmunization Responder Type and COVID‐19 Vaccine IgG Response in Patients with Sickle Cell Disease

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 63; no. S5; pp. 159A - 160A
Main Authors Nakahara, H., Cheedarla, N., Verkerke, H., Cheedarla, S., Wu, S., Hendrickson, J., Roback, J., Neish, A., Fasano, R., Stowell, S.
Format Journal Article
LanguageEnglish
Published Bethesda Wiley Subscription Services, Inc 01.10.2023
Subjects
COVID-19
Immunoglobulin G
Isoimmunization
Sickle cell disease
Vaccines
Online AccessGet full text

Cover

More Information
ISSN:0041-1132
1537-2995
DOI:10.1111/trf.204_17554